Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential Adriamycin and Docetaxel in Breast Cancer
NCT00212082Phase 2Completed
- Sponsor
- National University Hospital
- Start
- Apr 2002
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of doxorubicin, docetaxel in breast cancer, sponsored by National University Hospital. Started Apr 2002; status: completed.
02
Drugs
doxorubicindocetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00212082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00212082.